Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
75.32
+1.84 (2.50%)
Apr 24, 2025, 2:45 PM CST
Xiamen Amoytop Biotech Revenue
In the year 2024, Xiamen Amoytop Biotech had annual revenue of 2.82B CNY with 34.13% growth. Xiamen Amoytop Biotech had revenue of 862.46M in the quarter ending December 31, 2024, with 34.65% growth.
Revenue
2.82B
Revenue Growth
+34.13%
P/S Ratio
10.36
Revenue / Employee
1.50M
Employees
1,960
Market Cap
30.51B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 27.98B |
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
WuXi AppTec | 37.92B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Aier Eye Hospital Group | 20.62B |
Shanghai United Imaging Healthcare | 10.30B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.03B |